- 1 analyst, 1 voteThe latest Buy, Hold or Sell from every analyst covering a stock.
- Price targetsTheir average target, the range, and the upside against today's price.
- Radar picks →The stocks our model scores highest in each index.
Russell 2000 analyst ratings
1,952 stocks · 1,852 covered · 15,462 votes ·
Ranking as of analyst data of 7 Nov 2026
| #Stock | Price · day | Buy / Hold / Sell | Avg target · range (USD) | Upside | Latest target report | Next earnings | Data status | Analysts | Report dates |
|---|---|---|---|---|---|---|---|---|---|
| 71.42+6.25% | Buy 12 · Hold 2 · Sell 0 · 86% Buy | 125.54100.00–145.00 | +75.8%+54.12 USD | 22 SepPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 03:29 ET | 1616 firms | avg 28 Jul30 Mar 2026 – 22 Sep 2026 | |
| 6.93+11.41% | Buy 12 · Hold 4 · Sell 0 · 75% Buy | 28.7113.00–46.00 | +314.3%+21.78 USD | 31 AugPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 08:12 ET | 1918 firms | avg 16 Jul14 May 2026 – 31 Aug 2026 | |
| 37.26+3.07% | Buy 12 · Hold 4 · Sell 0 · 75% Buy | 126.3846.00–192.00 | +239.2%+89.12 USD | 12 OctPartial coverage · checked 6 Nov | 12 NovConfirmed | Partial coverage6 Nov 05:53 ET | 1817 firms | avg 27 Jul13 Mar 2026 – 12 Oct 2026 | |
| 4.16−0.72% | Buy 12 · Hold 2 · Sell 0 · 86% Buy | 13.007.00–21.00 | +212.5%+8.84 USD | 30 SepPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:00 ET | 1514 firms | avg 8 Aug5 May 2026 – 30 Sep 2026 | |
| 7.33+8.43% | Buy 12 · Hold 2 · Sell 0 · 86% Buy | 37.3018.00–59.00 | +408.9%+29.97 USD | 14 SepPartial coverage · checked 6 Nov | 9 NovEstimated | Partial coverage6 Nov 06:19 ET | 1515 firms | avg 30 Jun9 Mar 2026 – 14 Sep 2026 | |
| 24.93−0.48% | Buy 12 · Hold 3 · Sell 0 · 80% Buy | 29.7927.00–32.00 | +19.5%+4.86 USD | 26 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:36 ET | 1515 firms | avg 25 Aug24 Jun 2026 – 26 Oct 2026 | |
| 16.62−0.30% | Buy 12 · Hold 4 · Sell 0 · 75% Buy | 20.5718.00–23.00 | +23.8%+3.95 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:52 ET | 1817 firms | avg 11 Aug6 Feb 2026 – 28 Oct 2026 | |
| 4.65+4.49% | Buy 12 · Hold 1 · Sell 0 · 92% Buy | 7.024.25–11.00 | +51.0%+2.37 USD | 1 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:53 ET | 1616 firms | avg 1 Jul4 Mar 2026 – 1 Oct 2026 | |
| 9.92−0.30% | Buy 12 · Hold 8 · Sell 0 · 60% Buy | 14.1910.00–19.00 | +43.1%+4.27 USD | 3 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:41 ET | 2118 firms | avg 7 Aug15 Apr 2026 – 3 Nov 2026 | |
| 17.81+6.14% | Buy 12 · Hold 3 · Sell 0 · 80% Buy | 20.9218.00–24.00 | +17.4%+3.11 USD | 24 SepPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 06:16 ET | 1615 firms | avg 17 Aug7 Aug 2026 – 24 Sep 2026 | |
| 16.91−6.00% | Buy 12 · Hold 12 · Sell 0 · 50% Buy | 27.4515.50–50.00 | +62.3%+10.54 USD | 13 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:01 ET | 2727 firms | avg 13 Jul20 Feb 2026 – 13 Oct 2026 | |
| 47.90+5.44% | Buy 12 · Hold 1 · Sell 0 · 92% Buy | 68.6031.00–95.00 | +43.2%+20.70 USD | 16 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 03:03 ET | 1414 firms | avg 23 Aug23 Apr 2026 – 16 Oct 2026 | |
| 133.77−0.69% | Buy 12 · Hold 4 · Sell 0 · 75% Buy | 160.85142.00–182.00 | +20.2%+27.08 USD | 29 OctPartial coverage · checked 6 Nov | 26 JanEstimated | Partial coverage6 Nov 02:35 ET | 1717 firms | avg 20 Sep30 Jun 2026 – 29 Oct 2026 | |
| 8.23+10.85% | Buy 12 · Hold 1 · Sell 0 · 92% Buy | 34.3321.00–45.00 | +317.4%+26.11 USD | 20 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 04:47 ET | 1414 firms | avg 20 Jul12 May 2026 – 20 Oct 2026 | |
| 8.41−10.34% | Buy 12 · Hold 1 · Sell 0 · 92% Buy | 17.0012.00–24.00 | +102.1%+8.59 USD | 16 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:13 ET | 1414 firms | avg 2 Oct7 Aug 2026 – 16 Oct 2026 | |
| 8.88+13.85% | Buy 12 · Hold 2 · Sell 0 · 86% Buy | 40.8232.00–50.00 | +359.7%+31.94 USD | 8 SepPartial coverage · checked 6 Nov | 10 NovConfirmed | Partial coverage6 Nov 07:00 ET | 1515 firms | avg 5 Jul14 Nov 2025 – 8 Sep 2026 | |
| 17.66+4.07% | Buy 12 · Hold 0 · Sell 1 · 92% Buy | 32.6425.00–42.00 | +84.8%+14.98 USD | 14 SepPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 03:24 ET | 1413 firms | avg 1 Jul6 May 2026 – 14 Sep 2026 | |
| 8.75+8.83% | Buy 12 · Hold 0 · Sell 1 · 92% Buy | 20.8915.00–29.00 | +138.7%+12.14 USD | 22 OctPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 06:13 ET | 1414 firms | avg 5 Jun8 Dec 2025 – 22 Oct 2026 | |
| 0.19+2.98% | Buy 12 · Hold 1 · Sell 1 · 86% Buy | 5.302.00–9.00 | +2,639.0%+5.11 USD | 6 AugPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 03:44 ET | 1514 firms | avg 4 Jun24 Mar 2026 – 6 Aug 2026 | |
| 300.88+0.21% | Buy 12 · Hold 1 · Sell 1 · 86% Buy | 383.89284.00–474.00 | +27.6%+83.01 USD | 3 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:36 ET | 1515 firms | avg 20 Aug18 Feb 2026 – 3 Nov 2026 | |
| 42.01+10.29% | Buy 12 · Hold 1 · Sell 1 · 86% Buy | 58.4235.00–80.00 | +39.1%+16.41 USD | 27 OctPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 06:08 ET | 1615 firms | avg 25 Aug26 May 2026 – 27 Oct 2026 | |
| 24.84−0.72% | Buy 12 · Hold 3 · Sell 1 · 75% Buy | 26.7824.50–30.00 | +7.8%+1.94 USD | 12 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:37 ET | 1918 firms | avg 24 Jul18 Feb 2026 – 12 Oct 2026 | |
| 65.44−0.35% | Buy 12 · Hold 3 · Sell 1 · 75% Buy | 98.2762.00–137.00 | +50.2%+32.83 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:10 ET | 1817 firms | avg 20 Aug20 Feb 2026 – 30 Oct 2026 | |
| 28.38+1.65% | Buy 12 · Hold 0 · Sell 1 · 92% Buy | 42.4137.00–50.00 | +49.4%+14.03 USD | 14 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:06 ET | 1413 firms | avg 8 Sep9 Jul 2026 – 14 Oct 2026 | |
175VCYTVERACYTE | 24.16+0.67% | Buy 12 · Hold 2 · Sell 1 · 80% Buy | 57.2344.00–69.00 | +136.9%+33.07 USD | 2 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:45 ET | 1615 firms | avg 15 Aug1 Jun 2026 – 2 Oct 2026 |
| 66.41−1.01% | Buy 12 · Hold 4 · Sell 2 · 67% Buy | 74.1760.00–85.00 | +11.7%+7.76 USD | 2 NovPartial coverage · checked 6 Nov | 3 FebEstimated | Partial coverage6 Nov 02:37 ET | 2222 firms | avg 7 Aug6 Feb 2026 – 2 Nov 2026 | |
| 91.97+5.00% | Buy 11 · Hold 4 · Sell 0 · 73% Buy | 121.6985.00–160.00 | +32.3%+29.72 USD | 7 OctPartial coverage · checked 6 Nov | 3 FebEstimated | Partial coverage6 Nov 02:55 ET | 1616 firms | avg 28 Jul12 Dec 2025 – 7 Oct 2026 | |
| 206.79+5.54% | Buy 11 · Hold 1 · Sell 0 · 92% Buy | 328.67300.00–374.00 | +58.9%+121.88 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:47 ET | 1312 firms | avg 10 Sep1 May 2026 – 30 Oct 2026 | |
| 19.42−0.26% | Buy 11 · Hold 2 · Sell 0 · 85% Buy | 23.1518.00–28.00 | +19.2%+3.73 USD | 13 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 03:31 ET | 1615 firms | avg 27 Jun2 Mar 2026 – 13 Oct 2026 | |
| 31.65+6.98% | Buy 11 · Hold 2 · Sell 0 · 85% Buy | 53.6735.00–67.00 | +69.6%+22.02 USD | 16 SepPartial coverage · checked 6 Nov | 9 NovEstimated | Partial coverage6 Nov 02:38 ET | 1514 firms | avg 2 Jun10 Nov 2025 – 16 Sep 2026 | |
| 2.19+2.34% | Buy 11 · Hold 1 · Sell 0 · 92% Buy | 12.096.00–16.00 | +452.1%+9.90 USD | 13 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:15 ET | 1312 firms | avg 21 Jun16 Mar 2026 – 13 Oct 2026 | |
| 38.21+2.77% | Buy 11 · Hold 4 · Sell 0 · 73% Buy | 43.6041.00–46.00 | +14.1%+5.39 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:35 ET | 2019 firms | avg 31 Aug22 Jan 2026 – 19 Oct 2026 | |
183ERASERASCA | 14.41+8.59% | Buy 11 · Hold 3 · Sell 0 · 79% Buy | 21.9316.00–30.00 | +52.2%+7.52 USD | 14 AugPartial coverage · checked 6 Nov | 11 NovEstimated | Partial coverage6 Nov 02:44 ET | 1717 firms | avg 4 Jun6 Mar 2026 – 14 Aug 2026 |
| 12.11−4.65% | Buy 11 · Hold 8 · Sell 0 · 58% Buy | 15.9412.00–25.00 | +31.6%+3.83 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:47 ET | 2119 firms | avg 14 Jul22 Jan 2026 – 28 Oct 2026 | |
| 38.90−1.97% | Buy 11 · Hold 4 · Sell 0 · 73% Buy | 47.0238.00–60.00 | +20.9%+8.12 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:41 ET | 1616 firms | avg 26 Jun12 Feb 2026 – 19 Oct 2026 | |
| 14.79+15.91% | Buy 11 · Hold 1 · Sell 0 · 92% Buy | 31.7021.00–42.00 | +114.3%+16.91 USD | 28 OctPartial coverage · checked 6 Nov | 12 NovConfirmed | Partial coverage6 Nov 06:54 ET | 1414 firms | avg 10 Aug1 Jun 2026 – 28 Oct 2026 | |
| 15.07+6.88% | Buy 11 · Hold 1 · Sell 0 · 92% Buy | 48.0925.00–77.00 | +219.1%+33.02 USD | 27 OctPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 06:12 ET | 1515 firms | avg 13 Jun25 Nov 2025 – 27 Oct 2026 | |
188LASRNLIGHT | 38.02+29.58% | Buy 11 · Hold 1 · Sell 0 · 92% Buy | 83.1340.00–100.00 | +118.6%+45.11 USD | 7 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:53 ET | 1414 firms | avg 28 Jun7 Nov 2025 – 7 Oct 2026 |
| 2.89−0.52% | Buy 11 · Hold 1 · Sell 0 · 92% Buy | 19.119.00–30.00 | +561.3%+16.22 USD | 25 OctPartial coverage · checked 6 Nov | 9 NovEstimated | Partial coverage6 Nov 06:56 ET | 1312 firms | avg 6 Jun10 Dec 2025 – 25 Oct 2026 | |
190PHRPHREESIA | 12.62−0.71% | Buy 11 · Hold 12 · Sell 0 · 48% Buy | 14.2910.00–20.00 | +13.3%+1.67 USD | 19 OctPartial coverage · checked 6 Nov | 2 DecConfirmed | Partial coverage6 Nov 06:19 ET | 2421 firms | avg 9 Jul24 Mar 2026 – 19 Oct 2026 |
| 15.43−0.90% | Buy 11 · Hold 15 · Sell 0 · 42% Buy | 24.8616.00–39.00 | +61.1%+9.43 USD | 15 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:00 ET | 2724 firms | avg 3 Sep15 Jun 2026 – 15 Oct 2026 | |
| 18.53−2.68% | Buy 11 · Hold 6 · Sell 0 · 65% Buy | 30.4325.00–37.00 | +64.2%+11.90 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:07 ET | 1917 firms | avg 21 Jul12 Dec 2025 – 30 Oct 2026 | |
| 3.03+3.06% | Buy 11 · Hold 1 · Sell 0 · 92% Buy | 11.556.00–16.00 | +281.0%+8.52 USD | 25 SepPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 07:04 ET | 1313 firms | avg 23 Jun11 May 2026 – 25 Sep 2026 | |
194SDRLSEADRILL | 42.20+2.63% | Buy 11 · Hold 2 · Sell 0 · 85% Buy | 56.5043.00–80.00 | +33.9%+14.30 USD | 22 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:46 ET | 1414 firms | avg 8 Jul9 Jan 2026 – 22 Oct 2026 |
| 60.35−5.50% | Buy 11 · Hold 4 · Sell 0 · 73% Buy | 69.9256.00–80.00 | +15.9%+9.57 USD | 12 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:54 ET | 1818 firms | avg 26 Jun16 Jan 2026 – 12 Oct 2026 | |
| 46.55+8.99% | Buy 11 · Hold 1 · Sell 0 · 92% Buy | 153.89104.00–283.00 | +230.6%+107.34 USD | 24 SepPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 08:12 ET | 1313 firms | avg 9 Jun23 Dec 2025 – 24 Sep 2026 | |
| 68.60+1.60% | Buy 11 · Hold 1 · Sell 0 · 92% Buy | 103.3389.00–116.00 | +50.6%+34.73 USD | 4 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:46 ET | 1310 firms | avg 3 Sep13 Jul 2026 – 4 Nov 2026 | |
| 20.64+6.28% | Buy 11 · Hold 2 · Sell 0 · 85% Buy | 73.9126.00–93.00 | +258.1%+53.27 USD | 11 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 07:07 ET | 1412 firms | avg 24 Jul13 Apr 2026 – 11 Oct 2026 | |
199VSECVSE CORP | 172.81+4.92% | Buy 11 · Hold 3 · Sell 0 · 79% Buy | 259.00215.00–290.00 | +49.9%+86.19 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:41 ET | 1514 firms | avg 2 Sep7 Aug 2026 – 28 Oct 2026 |
| 25.48−2.30% | Buy 11 · Hold 4 · Sell 0 · 73% Buy | 30.7124.00–35.00 | +20.5%+5.23 USD | 2 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:48 ET | 1817 firms | avg 9 Jul12 Dec 2025 – 2 Nov 2026 | |
- MNPR#151MONOPAR THERAPEUTICS71.42+6.25%
Buy 12 · Hold 2 · Sell 0 · 86% Buy
Target 125.54 (100.00–145.00)+75.8%
Details
- Latest target report
- 22 Sep 2026
- Report dates
- 30 Mar 2026 – 22 Sep 2026 · avg 28 Jul 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- MPLT#152MAPLIGHT THERAPEUTICS6.93+11.41%
Buy 12 · Hold 4 · Sell 0 · 75% Buy
Target 28.71 (13.00–46.00)+314.3%
Details
- Latest target report
- 31 Aug 2026
- Report dates
- 14 May 2026 – 31 Aug 2026 · avg 16 Jul 2026
- Analysts
- 19 analysts · 18 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- NKTR#153NEKTAR THERAPEUTICS37.26+3.07%
Buy 12 · Hold 4 · Sell 0 · 75% Buy
Target 126.38 (46.00–192.00)+239.2%
Details
- Latest target report
- 12 Oct 2026
- Report dates
- 13 Mar 2026 – 12 Oct 2026 · avg 27 Jul 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- 12 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- NUVB#154NUVATION BIO CLASS A4.16−0.72%
Buy 12 · Hold 2 · Sell 0 · 86% Buy
Target 13.00 (7.00–21.00)+212.5%
Details
- Latest target report
- 30 Sep 2026
- Report dates
- 5 May 2026 – 30 Sep 2026 · avg 8 Aug 2026
- Analysts
- 15 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- OLMA#155OLEMA PHARMACEUTICALS7.33+8.43%
Buy 12 · Hold 2 · Sell 0 · 86% Buy
Target 37.30 (18.00–59.00)+408.9%
Details
- Latest target report
- 14 Sep 2026
- Report dates
- 9 Mar 2026 – 14 Sep 2026 · avg 30 Jun 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- 9 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- ONB#156OLD NATIONAL BANCORP24.93−0.48%
Buy 12 · Hold 3 · Sell 0 · 80% Buy
Target 29.79 (27.00–32.00)+19.5%
Details
- Latest target report
- 26 Oct 2026
- Report dates
- 24 Jun 2026 – 26 Oct 2026 · avg 25 Aug 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- PINE#157ALPINE INCOME PROPERTY TRUST INC16.62−0.30%
Buy 12 · Hold 4 · Sell 0 · 75% Buy
Target 20.57 (18.00–23.00)+23.8%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 6 Feb 2026 – 28 Oct 2026 · avg 11 Aug 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- PRME#158PRIME MEDICINE4.65+4.49%
Buy 12 · Hold 1 · Sell 0 · 92% Buy
Target 7.02 (4.25–11.00)+51.0%
Details
- Latest target report
- 1 Oct 2026
- Report dates
- 4 Mar 2026 – 1 Oct 2026 · avg 1 Jul 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- PTEN#159PATTERSON UTI ENERGY INC9.92−0.30%
Buy 12 · Hold 8 · Sell 0 · 60% Buy
Target 14.19 (10.00–19.00)+43.1%
Details
- Latest target report
- 3 Nov 2026
- Report dates
- 15 Apr 2026 – 3 Nov 2026 · avg 7 Aug 2026
- Analysts
- 21 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- PUBM#160PUBMATIC CLASS A17.81+6.14%
Buy 12 · Hold 3 · Sell 0 · 80% Buy
Target 20.92 (18.00–24.00)+17.4%
Details
- Latest target report
- 24 Sep 2026
- Report dates
- 7 Aug 2026 – 24 Sep 2026 · avg 17 Aug 2026
- Analysts
- 16 analysts · 15 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- TNDM#161TANDEM DIABETES CARE16.91−6.00%
Buy 12 · Hold 12 · Sell 0 · 50% Buy
Target 27.45 (15.50–50.00)+62.3%
Details
- Latest target report
- 13 Oct 2026
- Report dates
- 20 Feb 2026 – 13 Oct 2026 · avg 13 Jul 2026
- Analysts
- 27 analysts · 27 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- TRAX#162FIRST TRACKS BIOTHERAPEUTICS INC47.90+5.44%
Buy 12 · Hold 1 · Sell 0 · 92% Buy
Target 68.60 (31.00–95.00)+43.2%
Details
- Latest target report
- 16 Oct 2026
- Report dates
- 23 Apr 2026 – 16 Oct 2026 · avg 23 Aug 2026
- Analysts
- 14 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- UMBF#163UMB FINANCIAL133.77−0.69%
Buy 12 · Hold 4 · Sell 0 · 75% Buy
Target 160.85 (142.00–182.00)+20.2%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 30 Jun 2026 – 29 Oct 2026 · avg 20 Sep 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- 26 Jan · Estimated
- Research
- Partial coverage · checked 6 Nov
- USAR#164USA RARE EARTH CLASS A8.23+10.85%
Buy 12 · Hold 1 · Sell 0 · 92% Buy
Target 34.33 (21.00–45.00)+317.4%
Details
- Latest target report
- 20 Oct 2026
- Report dates
- 12 May 2026 – 20 Oct 2026 · avg 20 Jul 2026
- Analysts
- 14 analysts · 14 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- VSTM#165VERASTEM INC8.41−10.34%
Buy 12 · Hold 1 · Sell 0 · 92% Buy
Target 17.00 (12.00–24.00)+102.1%
Details
- Latest target report
- 16 Oct 2026
- Report dates
- 7 Aug 2026 – 16 Oct 2026 · avg 2 Oct 2026
- Analysts
- 14 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- WYFI#166WHITEFIBER INC8.88+13.85%
Buy 12 · Hold 2 · Sell 0 · 86% Buy
Target 40.82 (32.00–50.00)+359.7%
Details
- Latest target report
- 8 Sep 2026
- Report dates
- 14 Nov 2025 – 8 Sep 2026 · avg 5 Jul 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- 10 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- AVNW#167AVIAT NETWORKS INC17.66+4.07%
Buy 12 · Hold 0 · Sell 1 · 92% Buy
Target 32.64 (25.00–42.00)+84.8%
Details
- Latest target report
- 14 Sep 2026
- Report dates
- 6 May 2026 – 14 Sep 2026 · avg 1 Jul 2026
- Analysts
- 14 analysts · 13 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CADL#168CANDEL THERAPEUTICS INC8.75+8.83%
Buy 12 · Hold 0 · Sell 1 · 92% Buy
Target 20.89 (15.00–29.00)+138.7%
Details
- Latest target report
- 22 Oct 2026
- Report dates
- 8 Dec 2025 – 22 Oct 2026 · avg 5 Jun 2026
- Analysts
- 14 analysts · 14 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- CNTX#169CONTEXT THERAPEUTICS INC0.19+2.98%
Buy 12 · Hold 1 · Sell 1 · 86% Buy
Target 5.30 (2.00–9.00)+2,639.0%
Details
- Latest target report
- 6 Aug 2026
- Report dates
- 24 Mar 2026 – 6 Aug 2026 · avg 4 Jun 2026
- Analysts
- 15 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- KRYS#170KRYSTAL BIOTECH300.88+0.21%
Buy 12 · Hold 1 · Sell 1 · 86% Buy
Target 383.89 (284.00–474.00)+27.6%
Details
- Latest target report
- 3 Nov 2026
- Report dates
- 18 Feb 2026 – 3 Nov 2026 · avg 20 Aug 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- LBRX#171LB PHARMACEUTICALS INC42.01+10.29%
Buy 12 · Hold 1 · Sell 1 · 86% Buy
Target 58.42 (35.00–80.00)+39.1%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 26 May 2026 – 27 Oct 2026 · avg 25 Aug 2026
- Analysts
- 16 analysts · 15 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- MAC#172MACERICH REIT24.84−0.72%
Buy 12 · Hold 3 · Sell 1 · 75% Buy
Target 26.78 (24.50–30.00)+7.8%
Details
- Latest target report
- 12 Oct 2026
- Report dates
- 18 Feb 2026 – 12 Oct 2026 · avg 24 Jul 2026
- Analysts
- 19 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- PTCT#173PTC THERAPEUTICS65.44−0.35%
Buy 12 · Hold 3 · Sell 1 · 75% Buy
Target 98.27 (62.00–137.00)+50.2%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 20 Feb 2026 – 30 Oct 2026 · avg 20 Aug 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SSRM#174SSR MINING28.38+1.65%
Buy 12 · Hold 0 · Sell 1 · 92% Buy
Target 42.41 (37.00–50.00)+49.4%
Details
- Latest target report
- 14 Oct 2026
- Report dates
- 9 Jul 2026 – 14 Oct 2026 · avg 8 Sep 2026
- Analysts
- 14 analysts · 13 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- VCYT#175VERACYTE24.16+0.67%
Buy 12 · Hold 2 · Sell 1 · 80% Buy
Target 57.23 (44.00–69.00)+136.9%
Details
- Latest target report
- 2 Oct 2026
- Report dates
- 1 Jun 2026 – 2 Oct 2026 · avg 15 Aug 2026
- Analysts
- 16 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- TRNO#176TERRENO REALTY REIT66.41−1.01%
Buy 12 · Hold 4 · Sell 2 · 67% Buy
Target 74.17 (60.00–85.00)+11.7%
Details
- Latest target report
- 2 Nov 2026
- Report dates
- 6 Feb 2026 – 2 Nov 2026 · avg 7 Aug 2026
- Analysts
- 22 analysts · 22 firms
- Next earnings
- 3 Feb · Estimated
- Research
- Partial coverage · checked 6 Nov
- ALGT#177ALLEGIANT TRAVEL91.97+5.00%
Buy 11 · Hold 4 · Sell 0 · 73% Buy
Target 121.69 (85.00–160.00)+32.3%
Details
- Latest target report
- 7 Oct 2026
- Report dates
- 12 Dec 2025 – 7 Oct 2026 · avg 28 Jul 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- 3 Feb · Estimated
- Research
- Partial coverage · checked 6 Nov
- BELFB#178BEL FUSE CLASS B206.79+5.54%
Buy 11 · Hold 1 · Sell 0 · 92% Buy
Target 328.67 (300.00–374.00)+58.9%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 1 May 2026 – 30 Oct 2026 · avg 10 Sep 2026
- Analysts
- 13 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- BOBS#179BOBS DISCOUNT FURNITURE INC19.42−0.26%
Buy 11 · Hold 2 · Sell 0 · 85% Buy
Target 23.15 (18.00–28.00)+19.2%
Details
- Latest target report
- 13 Oct 2026
- Report dates
- 2 Mar 2026 – 13 Oct 2026 · avg 27 Jun 2026
- Analysts
- 16 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- COGT#180COGENT BIOSCIENCES31.65+6.98%
Buy 11 · Hold 2 · Sell 0 · 85% Buy
Target 53.67 (35.00–67.00)+69.6%
Details
- Latest target report
- 16 Sep 2026
- Report dates
- 10 Nov 2025 – 16 Sep 2026 · avg 2 Jun 2026
- Analysts
- 15 analysts · 14 firms
- Next earnings
- 9 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- CTMX#181CYTOMX THERAPEUTICS2.19+2.34%
Buy 11 · Hold 1 · Sell 0 · 92% Buy
Target 12.09 (6.00–16.00)+452.1%
Details
- Latest target report
- 13 Oct 2026
- Report dates
- 16 Mar 2026 – 13 Oct 2026 · avg 21 Jun 2026
- Analysts
- 13 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CTRE#182CARETRUST REIT38.21+2.77%
Buy 11 · Hold 4 · Sell 0 · 73% Buy
Target 43.60 (41.00–46.00)+14.1%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 22 Jan 2026 – 19 Oct 2026 · avg 31 Aug 2026
- Analysts
- 20 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ERAS#183ERASCA14.41+8.59%
Buy 11 · Hold 3 · Sell 0 · 79% Buy
Target 21.93 (16.00–30.00)+52.2%
Details
- Latest target report
- 14 Aug 2026
- Report dates
- 6 Mar 2026 – 14 Aug 2026 · avg 4 Jun 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- 11 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- FRSH#184FRESHWORKS CLASS A12.11−4.65%
Buy 11 · Hold 8 · Sell 0 · 58% Buy
Target 15.94 (12.00–25.00)+31.6%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 22 Jan 2026 – 28 Oct 2026 · avg 14 Jul 2026
- Analysts
- 21 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- HASI#185HA SUSTAINABLE INFRASTRUCTURE CAPI38.90−1.97%
Buy 11 · Hold 4 · Sell 0 · 73% Buy
Target 47.02 (38.00–60.00)+20.9%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 12 Feb 2026 – 19 Oct 2026 · avg 26 Jun 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- HAWK#186HAWKEYE INC14.79+15.91%
Buy 11 · Hold 1 · Sell 0 · 92% Buy
Target 31.70 (21.00–42.00)+114.3%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 1 Jun 2026 – 28 Oct 2026 · avg 10 Aug 2026
- Analysts
- 14 analysts · 14 firms
- Next earnings
- 12 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- JBIO#187JADE BIOSCIENCES15.07+6.88%
Buy 11 · Hold 1 · Sell 0 · 92% Buy
Target 48.09 (25.00–77.00)+219.1%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 25 Nov 2025 – 27 Oct 2026 · avg 13 Jun 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- LASR#188NLIGHT38.02+29.58%
Buy 11 · Hold 1 · Sell 0 · 92% Buy
Target 83.13 (40.00–100.00)+118.6%
Details
- Latest target report
- 7 Oct 2026
- Report dates
- 7 Nov 2025 – 7 Oct 2026 · avg 28 Jun 2026
- Analysts
- 14 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- LXEO#189LEXEO THERAPEUTICS2.89−0.52%
Buy 11 · Hold 1 · Sell 0 · 92% Buy
Target 19.11 (9.00–30.00)+561.3%
Details
- Latest target report
- 25 Oct 2026
- Report dates
- 10 Dec 2025 – 25 Oct 2026 · avg 6 Jun 2026
- Analysts
- 13 analysts · 12 firms
- Next earnings
- 9 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- PHR#190PHREESIA12.62−0.71%
Buy 11 · Hold 12 · Sell 0 · 48% Buy
Target 14.29 (10.00–20.00)+13.3%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 24 Mar 2026 – 19 Oct 2026 · avg 9 Jul 2026
- Analysts
- 24 analysts · 21 firms
- Next earnings
- 2 Dec · Confirmed
- Research
- Partial coverage · checked 6 Nov
- RARE#191ULTRAGENYX PHARMACEUTICAL15.43−0.90%
Buy 11 · Hold 15 · Sell 0 · 42% Buy
Target 24.86 (16.00–39.00)+61.1%
Details
- Latest target report
- 15 Oct 2026
- Report dates
- 15 Jun 2026 – 15 Oct 2026 · avg 3 Sep 2026
- Analysts
- 27 analysts · 24 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- RVLV#192REVOLVE GROUP CLASS A18.53−2.68%
Buy 11 · Hold 6 · Sell 0 · 65% Buy
Target 30.43 (25.00–37.00)+64.2%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 12 Dec 2025 – 30 Oct 2026 · avg 21 Jul 2026
- Analysts
- 19 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SABS#193SAB BIOTHERAPEUTICS3.03+3.06%
Buy 11 · Hold 1 · Sell 0 · 92% Buy
Target 11.55 (6.00–16.00)+281.0%
Details
- Latest target report
- 25 Sep 2026
- Report dates
- 11 May 2026 – 25 Sep 2026 · avg 23 Jun 2026
- Analysts
- 13 analysts · 13 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SDRL#194SEADRILL42.20+2.63%
Buy 11 · Hold 2 · Sell 0 · 85% Buy
Target 56.50 (43.00–80.00)+33.9%
Details
- Latest target report
- 22 Oct 2026
- Report dates
- 9 Jan 2026 – 22 Oct 2026 · avg 8 Jul 2026
- Analysts
- 14 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SKWD#195SKYWARD SPECIALTY INSURANCE GROUP60.35−5.50%
Buy 11 · Hold 4 · Sell 0 · 73% Buy
Target 69.92 (56.00–80.00)+15.9%
Details
- Latest target report
- 12 Oct 2026
- Report dates
- 16 Jan 2026 – 12 Oct 2026 · avg 26 Jun 2026
- Analysts
- 18 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SPRB#196SPRUCE BIOSCIENCES46.55+8.99%
Buy 11 · Hold 1 · Sell 0 · 92% Buy
Target 153.89 (104.00–283.00)+230.6%
Details
- Latest target report
- 24 Sep 2026
- Report dates
- 23 Dec 2025 – 24 Sep 2026 · avg 9 Jun 2026
- Analysts
- 13 analysts · 13 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- TARS#197TARSUS PHARMACEUTICALS68.60+1.60%
Buy 11 · Hold 1 · Sell 0 · 92% Buy
Target 103.33 (89.00–116.00)+50.6%
Details
- Latest target report
- 4 Nov 2026
- Report dates
- 13 Jul 2026 – 4 Nov 2026 · avg 3 Sep 2026
- Analysts
- 13 analysts · 10 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- TECX#198TECTONIC THERAPEUTIC20.64+6.28%
Buy 11 · Hold 2 · Sell 0 · 85% Buy
Target 73.91 (26.00–93.00)+258.1%
Details
- Latest target report
- 11 Oct 2026
- Report dates
- 13 Apr 2026 – 11 Oct 2026 · avg 24 Jul 2026
- Analysts
- 14 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- VSEC#199VSE CORP172.81+4.92%
Buy 11 · Hold 3 · Sell 0 · 79% Buy
Target 259.00 (215.00–290.00)+49.9%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 7 Aug 2026 – 28 Oct 2026 · avg 2 Sep 2026
- Analysts
- 15 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- WRBY#200WARBY PARKER CLASS A25.48−2.30%
Buy 11 · Hold 4 · Sell 0 · 73% Buy
Target 30.71 (24.00–35.00)+20.5%
Details
- Latest target report
- 2 Nov 2026
- Report dates
- 12 Dec 2025 – 2 Nov 2026 · avg 9 Jul 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
Showing 151–200 of 1,952Load more
About the Russell 2000 analyst ratings
US small-cap stocks in the Russell 2000. Smaller companies usually have fewer analysts.. For each stock Analyst Radar counts the latest Buy, Hold or Sell rating of every analyst who covers it within the chosen window (one vote per analyst) and averages their price targets in US dollars. Upside is the average target against the current price; the range is the lowest and highest target. The stocks our model scores highest are collected in Radar picks. Research is refreshed daily and prices stream live during the US session.
A summary of analyst opinion, not investment advice.